Nordisk

Novo Nordisk signage on the floor of the New York Stock Exchange in New York, US, on Friday, Jan. 2, 2026.Michael…
Read More...

A pharmacist displays a box of Wegovy pills at a pharmacy in Provo, Utah, US, on Thursday, Jan. 15, 2026. George Frey…
Read More...

The booming GLP-1 space was built on weekly injections. In 2026, new obesity pills will push the market into its next…
Read More...

The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, on the outskirts…
Read More...

Still life of the big three injectable prescription weight loss medicines. Ozempic, Victoza and Wegovy. (Photo by:…
Read More...

Ozempic is medicine for adults with type 2 diabetes that along with diet and exercise may improve blood sugar. (Photo…
Read More...

Shares in Novo Nordisk surged 6% Tuesday, after the Wegovy maker secured approval of its GLP-1 pill — a world first.…
Read More...

The U.S. Food and Drug Administration on Monday approved the first-ever GLP-1 pill for obesity from Wegovy maker Novo…
Read More...

Drug pricing has emerged as a key topic to watch for pharmaceutical companies and investors in 2025. As President…
Read More...

The Novo Nordisk A/S headquarters in Bagsvaerd, Denmark, on Wednesday, Nov. 5, 2025. Nichlas Pollier | Bloomberg |…
Read More...